Immunoreactivity and prognostic value of tumor-associated glycoprotein 72 in primary gallbladder carcinoma

Surgical Oncology

Volumn 19, Issue 2, 2010, Pages 82-87

  Ouyang, Miao ^a   Wu, Wei ^a   Zou, Yiyou ^a   Zhou, Jun ^a   Wang, Zhiming ^a   Wan, Xiaoping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Clinicopathology; Immunohistochemistry; Primary gallbladder carcinoma; Prognosis; Tumor associated glycoprotein 72

Indexed keywords

GLYCOPROTEIN; PROTEIN ANTIBODY; TAG 72 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CHRONIC CHOLECYSTITIS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; GALLBLADDER CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MALE; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SURVIVAL RATE; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGED; ANTIGENS, NEOPLASM; CARCINOMA; CHINA; CHOLECYSTITIS; FEMALE; GALLBLADDER NEOPLASMS; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPH NODES; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TUMOR MARKERS, BIOLOGICAL;

EID: 77952553690     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2009.03.010     Document Type: Review

References (25)

1. Sasaki E., Nagino M., Ebata T., Oda K., Arai T., Nishio H., et al. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with gallbladder carcinoma. Ann Surg 1 (2006) 99-105
2. Kondo S., Nimura Y., Kamiya J., Nagino M., Kanai M., Uesaka K., et al. Factors influencing postoperative hospital mortality and long-term survival after radical resection for stage IV gallbladder carcinoma. World J Surg 27 (2003) 272-277
3. Sai K., and Kajiwara H. An immunohistochemical study of metaplastic endocrine cells in human gallbladder cancer. J Hepatobiliary Pancreat Surg 8 (2001) 453-460
4. Cubertafond P., Gainant A., and Cucchiaro G. Surgical treatment of 724 carcinoma of the gallbladder. Results of French Surgical Association. Surv Ann Surg 219 (1994) 275-280
5. Wang B., Zhai H., Chen B., Zhai S.P., Yang H.Y., Chen X.P., et al. Clinical relationship between MDR1 gene and gallbladder cancer. Hepatobiliary Pancreat Dis Int 3 (2004) 296-299
6. Joseph Kelly F., Ryan Miller C., Buchsbaum D.J., Gomez-Navarro J., Barnes M.N., Alvarez R.D., et al. Selectivity of TAG-72-targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitro. Clin Cancer Res 6 (2000) 4323-4333
7. Alvarez R.D., Partridge E.E., Khazaeli M.B., Plott G., Austin M., Kilgore L., et al. Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II study. Gynecol Oncol 65 (1997) 94-101
8. Meredith R.F., Partridge E.E., Alvarez R.D., Khazaeli M.B., Plott G., Russell C.D., et al. Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49. J Nucl Med 37 (1996) 1491-1496
9. Japanese Society of Biliary Surgery. General rules for surgical and pathological studies on cancer of biliary tract. 5th ed. (2003), Kanehara, Tokyo
10. In: Sobin L.H., and Wittekind C. (Eds). International Union Against Cancer (UICC): TNM classification of malignant tumours. 6th ed. (2002), Wiley-Liss, New York
11. Shi J.S., Zhou L.S., Han Y., Zhu A.J., Sun X.J., and Yang Y.J. Expression of tumor necrosis factor and its receptor in gallstone and gallbladder carcinoma tissue. Hepatobiliary Pancreat Dis Int 3 (2004) 448-452
12. Hongyong X.U., Li X.U., Jianhong G.A.O., and Kaizong L.I. Detection of TAG-72 expression in human primary gallbladder carcinoma and its significance. Med J Shandong 3 (2007) 16-18
13. Takagawa M., Muguruma N., Oguri K., Imoto Y., Okamoto K., Kunio I.I., et al. Prediction of prognosis in gallbladder carcinoma by mucin and p53 immunohistochemistry. Dig Dis Sci 50 (2005) 1410-1413
14. Ito H., Matros E., Brooks D.C., Osteen R.T., Zinner M.J., Swanson R.S., et al. Treatment outcomes associated with surgery for gallbladder cancer: a 20-year experience. J Gastrointest Surg 8 (2004) 183-190
15. Pizzi C., Sgambato A., De Laurentiis M., Limite G., Panico L., Pettinato G., et al. TAG-72 expression and clinical outcome in primary breast cancer. Oncol Rep 6 (1999) 1399-1403
16. Castagna M., Nuti M., and Squartini F. Mammary cancer antigen recognized by monoclonal antibody B72.3 in apocrine metaplasia of the human breast. Cancer Res 47 (1987) 902-906
17. Soomro S., and Shousha S. Monoclonal antibody B72.3 in benign breast lesions. J Clin Pathol 43 (1990) 1026-1028
18. Contegiacomo A., Alimandi M., Muraro R., Pizzi C., Calderopoli R., De Marchis L., et al. Expression of epitopes of the tumour-associated glycoprotein 72 and clinicopathological correlations in mammary carcinomas. Eur J Cancer 6 (1994) 813-820
19. Chhieng D.C., Rodriguez-Burford C., Talley L.I., Sviglin H., Stockard C.R., Kleinberg M.J., et al. Expression of CEA, Tag-72, and Lewis-Y antigen in primary and metastatic lesions of ovarian carcinoma. Hum Pathol 34 (2003) 1016-1021
20. Epivatianos A., Poulopoulos A., Kayavis I., and Papanayotou P. Tumor-associated glycoprotein 72 (TAG-72) expression in salivary gland neoplasia: an immunohistochemical study using the monoclonal antibody (MAb) CC49. Oral Dis 6 (2000) 112-117
21. Galietta A., Pizzi C., Pettinato G., Limite G., Sgambato A., Lamberti M., et al. Differential TAG-72 epitope expression in breast cancer and lymph node metastases: a marker of a more aggressive phenotype. Oncol Rep 9 (2002) 135-140
22. Karan D., Johansson S.L., Lin M.F., and Batra S.K. Expression of tumor-associated glycoprotein-72 (TAG-72) antigen in human prostatic adenocarcinomas. Oncol Rep 8 (2000) 1123-1126
23. Peláez Buján Mdel C., Ruibal Morell A., and Aza González J. Gastric carcinoma: expression of c-erbB-2/neu oncoprotein, epidermal growth factor receptor, cathepsin D, progesterone receptor and tumor associated glycoprotein-72 in different histological types. Rev Esp Enferm Dig 91 (1999) 826-837
24. Yoon S.O., Lee T.S., Kim S.J., Jang M.H., Kang Y.J., Park J.H., et al. Construction, affinity maturation, and biological characterization of an anti-tumor-associated glycoprotein-72 humanized antibody. J Biol Chem 281 (2006) 6985-6992
25. Chauhan S.C., Vinayek N., Maher D.M., Bell M.C., Dunham K.A., Koch M.D., et al. Combined staining of TAG-72, MUC1, and CA125 improves labeling sensitivity in ovarian cancer: antigens for multi-targeted antibody-guided therapy. J Histochem Cytochem 55 (2007) 867-875